Latest News
Press background on Morepen Laboratories
Company profile
Some things will always remain unfettered. Like sunshine and air, like suffering and joy, like sharing and caring. Some things will never recognize the confines of space and time. Like human endeavour and enterprise, like the desire to touch life. At Morepen, we are taking our expertise and experience in Wellness to new countries and new people with an increasing focus on global exports. And in doing so, our spirit of caring is crossing boundaries.
 Recent press releases
Morepen Labs Strengthens its Position in Bulk Drugs Market for Montelukast and Rosuvastatin

Morepen Laboratories Ltd. has reported a 60 per cent rise in its net profit for the first quarter (Q1) of FY 2016-17. The net profit increased from Rs. 2.50 crore in the Q1 of the previous financial year to Rs. 4.01 crore in Q1 of FY 2016-17. The company ascribes its fifth consecutive quart... (more)
Share
Morepen Laboratories Reports 203% Rise in Net Profit and 15% Rise in Total Income in First Nine Months of Current Fiscal

- Company scores market leadership for Anti-asthmatic drug - Montelukast
- The drug likely to become the next blockbuster for the co. after Loratadine
 
Morepen Laboratories Ltd, one of the largest producers of Montelukast Sodium (an anti-asthmatic drug), in glo... (more)
Share